Business Description
Bluejay Diagnostics Inc
NAICS : 325413
SIC : 5047
ISIN : US0956333019
Description
Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 23.88 | |||||
| Equity-to-Asset | 0.86 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -86.8 | |||||
| 3-Year EPS without NRI Growth Rate | -67.9 | |||||
| 3-Year FCF Growth Rate | -127.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 94.73 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.81 | |||||
| 9-Day RSI | 44.53 | |||||
| 14-Day RSI | 45.7 | |||||
| 6-1 Month Momentum % | -97.96 | |||||
| 12-1 Month Momentum % | -99.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.26 | |||||
| Quick Ratio | 6.26 | |||||
| Cash Ratio | 5.49 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15.7 | |||||
| Shareholder Yield % | -569.36 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -157.4 | |||||
| ROA % | -114.8 | |||||
| ROIC % | -425.6 | |||||
| ROC (Joel Greenblatt) % | -484.8 | |||||
| ROCE % | -145.89 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.19 | |||||
| Price-to-Tangible-Book | 0.19 | |||||
| EV-to-EBIT | 0.43 | |||||
| EV-to-EBITDA | 0.44 | |||||
| EV-to-FCF | 0.38 | |||||
| Price-to-Net-Current-Asset-Value | 0.25 | |||||
| Price-to-Net-Cash | 0.29 | |||||
| Earnings Yield (Greenblatt) % | 232.56 | |||||
| FCF Yield % | -440.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BJDX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bluejay Diagnostics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1373 | ||
| Beta | 0.69 | ||
| Volatility % | 95.29 | ||
| 14-Day RSI | 45.7 | ||
| 14-Day ATR ($) | 0.815662 | ||
| 20-Day SMA ($) | 4.1485 | ||
| 12-1 Month Momentum % | -99.7 | ||
| 52-Week Range ($) | 3.03 - 1128 | ||
| Shares Outstanding (Mil) | 0.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bluejay Diagnostics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bluejay Diagnostics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bluejay Diagnostics Inc Frequently Asked Questions
What is Bluejay Diagnostics Inc(BJDX)'s stock price today?
The current price of BJDX is $3.70. The 52 week high of BJDX is $1128.00 and 52 week low is $3.03.
When is next earnings date of Bluejay Diagnostics Inc(BJDX)?
The next earnings date of Bluejay Diagnostics Inc(BJDX) is 2025-02-07 Est..
Does Bluejay Diagnostics Inc(BJDX) pay dividends? If so, how much?
Bluejay Diagnostics Inc(BJDX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers